A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

References

Page 1

	Year	Citations
Scottish Intercollegiate Guidelines Network Sara Twaddle, Safia Qureshi Evidence-based Healthcare and Public Health Scholarly CommunicationCommunity Engagement	2005	4.1K
Guidelines for Methacholine and Exercise Challenge Testing—1999 Robert O. Crapo, Richard Casaburi, Allan L. Coates, American Journal of Respiratory and Critical Care Medicine Physical ActivityKinesiologyExercisePhysical FitnessExercise Physiology	2000	2.5K
British Guideline on the Management of Asthma Thorax AsthmaVirus EpidemiologyViral DiagnosticsAllergy MedicineImmunodeficiencies	2008	2K
Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry Manuel D. Cerqueira, Mario S. Verani, Markus Schwaiger, Journal of the American College of Cardiology	1994	462
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli, Journal of Nuclear Cardiology Multicenter International TrialRadiologyHealth SciencesMedical ImagingCardiovascular Disease	2007	341
Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Manuel D. Cerqueira, Patricia K. Nguyen, Peter Staehr, JACC. Cardiovascular imaging ObesityMetabolic SyndromeHealth SciencesCardiovascular DiseaseMyocardial Perfusion Imaging	2008	240
Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study Jean Lette, James L. Tatum, Sheila Fraser, Journal of Nuclear Cardiology MedicineToxicologyPharmacology	1995	198
The A2A Adenosine Receptor Mediates Coronary Vasodilation Luiz Belardinelli, John C. Shryock, Stephen Snowdy, Journal of Pharmacology and Experimental Therapeutics	1998	179
Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging Robert C. Hendel, Timothy M. Bateman, Manuel D. Cerqueira, Journal of the American College of Cardiology EngineeringCardiovascular Translational ResearchMedical ImagingCardiovascular DiseaseMyocardial Infarction	2005	127
Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists Zhenhai Gao, Zhihe Li, Stephen P. Baker, Journal of Pharmacology and Experimental Therapeutics	2001	120

Page 1